Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT03755856
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of all subtypes of de novo AML, according to WHO criteria (at least 20% blasts in the bone marrow), except acute promyelocytic leukemia (APL).
* Age at AML diagnosis ≥ 18 years,
* Date of AML diagnosis at least 5 years before study enrollment,
* AML-free status at study enrollment,
* Written informed consent provided.
Exclusion Criteria:
* Major cognitive deficit or psychiatric problems hampering a self-reported evaluation,
* Not speaking and reading the language of the participating country,
* More than 75 years at the time of study enrollment,
* Receiving any active treatment for AML at the time of study enrollment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03755856
Study Brief:
Protocol Section:
NCT03755856